期刊文献+

醒脑静治疗重型颅脑损伤疗效观察 被引量:10

Therapeutic effect of Xingnaojing on severe traumatic brain injury
原文传递
导出
摘要 目的 探讨醒脑静治疗重型颅脑损伤(severe traumatic brain injury,sTBI)的疗效和安全性。方法 60例sTBI患者随机分为对照组及观察组各30例,对照组给予脱水、抗感染、纠正水电解质紊乱、营养支持等常规治疗,并根据需要行标准颅脑外伤去大骨瓣开颅手术联合亚低温治疗,观察组在对照组治疗基础上给予醒脑静注射液30 mL+生理盐水250mL,1次/d,连续7d。比较2组入院时、治疗7d后血清S100B蛋白、髓鞘碱性蛋白(myelin basic protein,MBP)和神经元特异性烯醇化酶(neuron-specific enolase,NSE)水平及格拉斯哥昏迷评分(Glasgow Coma Score,GCS)变化。结果 观察组、对照组治疗7d后血清S100B[(0.85±0.11)、(1.17±0.21)mg/L]、MBP[(6.49±1.01)、(9.35±1.72)mg/L]和NSE[(11.16±1.81)、(18.03±1.79)mg/L]水平均较入院时[S100B(1.62±0.23)、(1.61±0.38)mg/L,MBP(15.07±2.32)、(14.51±2.20)mg/L,NSE(37.51±1.84)、(37.27±1.96)mg/L]降低(P〈0.05),观察组较对照组降低明显(P〈0.05);观察组治疗7d后GCS评分〉12-15分比例(60.0%)高于对照组(30.0%)(P〈0.05)。结论 在常规治疗基础上应用醒脑静可降低sTBI患者血清S100B、MBP和NSE水平,改善患者昏迷程度。 Objective To study the therapeutic effect and safety of Xingnaojing in the treatment of severe traumatic brain injury (sTBI). Methods Sixty patients with sTBI were randomly divided into control group and observation group, with 30 patients in each group. Control group received conventional treatment including dehydration, anti-infection, adjusting water-electrolyte imbalance and nutrition supporting, and were performed standard large eraniotomy plus hypothermia treatment, besides which observation group received intravenous injection of 30 mL Xingnaojing + 250 mL normal saline once a day, totally for 7 days. The concentrations of S100B protein, myelin basic protein (MBP) and neuron-specific enolase (NSE) in plasma were recorded at admission and after 7-day treatment as well as the Glasgow Coma Score (GCS) after 7-day treatment and compared between two groups. Results The serum levels of S100B ((0.85±0.11), (1.17± 0.21) mg/L), MBP ((6. 49±1.01), (9. 35±1. 72) mg/L) and NSE ((11. 16±1. 81), (18. 03±1. 79) mg/L) in observation group and control group were lower after 7-day treatment than those at admission (S100B: (1.62 ± 0.23), (1.61±0.38) rag/L; MBP:(15.07±2.32), (14. 51±2. 20) ms/L; NSE: (37. 51±1. 84), (37. 27±1. 96) mg/L) (P〈0.05), which were more obvious in observation group than in control group (P〈0.05). The percentage of GCS 12 to 15 after 7-day treatment in observation group (60.0%) was higher than that in control group (30.0%) (P〈0.05). Conclusion Application of Xingnaojing plus the conventional therapy can reduce the concentrations of S100B, MBP and NSE, and alleviate the degree of coma in sTBI patients.
出处 《中华实用诊断与治疗杂志》 2015年第12期1237-1238,1241,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 武警后勤学院附属医院种子基金(FYM201417)
关键词 重型颅脑创伤 醒脑静 S100B蛋白 髓鞘碱性蛋白 神经元特异性烯醇化酶 Severe traumatic brain injury Xingnaojing S100B protein myelin basic protein neuron-specific enolase
  • 相关文献

参考文献8

二级参考文献66

  • 1中华医学会儿科学分会新生儿学组.新生儿缺氧缺血性脑病诊断标准[J].中华儿科杂志,2005,43(8):584-584. 被引量:1299
  • 2方成志,蔡宝珍,刘汉楚,陈小培,吴燕.肾上腺髓质素与新生儿缺氧缺血性脑病的关系[J].卒中与神经疾病,2007,14(3):159-161. 被引量:4
  • 3Celtik C, Acunas B, Oner N. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy[J]. Brain & Development, 2004, 26(6): 398-402.
  • 4Schanne FAX,Kane AB,Young EE,et al.Calcium dependence of toxic cell death:a final common pathway[J].Sci-ence,1979,206:700-702.
  • 5Hayes RL,Jenkins LW,Lyeth BG.Neurotransmitter mediated mechanisms of traumatic brain injury:acetycholine and excitatory amino acids.J Neurotrauma,1992;9:S173-187.
  • 6Bullock R,chesnut RM,Clifton G,et al.Guidelines for the management of severe head injury.Brain Trauma Foun-dation.Evr Emerg Med,1996,3:109-127.
  • 7Holmins,Mathiesen T.Intracerebral administration of Interlukin-1beta and induction of inflammation,apoptosis and vasogenic edemA.J Neurosurg,2000,92:108-120.
  • 8Toulmond S,Rothwell NJ,Luheshi G.Interlukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat[J].Brain Res,1995,671:261-266.
  • 9Hu J,Ferreria A,Van Eldik LJ,et al.S100B,a neuro-trophic protein that modulates neuronal cell through nitric oxide release from astrocytes.J Neurochem,1997,69:2294-2301.
  • 10Mrak RE,Sheng JG,Giffin WS.Glial cytokines in Alzheimer’s disease:review and pathogenic implications.Hum pathol,1995,26:816-823.

共引文献42

同被引文献88

引证文献10

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部